Thomas Vogl

Title: Innovations of Thomas Vogl

Introduction

Thomas Vogl is a notable inventor based in Muenster, Germany. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of two patents to his name, Vogl's work focuses on the quantification of S100A12 and the diagnosis of inflammatory diseases.

Latest Patents

Vogl's latest patents include "Complex-specific standardization of immunological methods for the quantification of S100A12." This invention relates to mutants of S100A12 that have mutations in the calcium binding hands or the zinc binding region. It also encompasses methods for detecting S100A12 dimers in samples and diagnostic compositions that utilize these mutants. Another significant patent is "Quinoline-3-carboxamide compounds and their use in diagnosis." This application provides compounds that are covalently linked to a label for diagnosing inflammatory diseases at local sites. These compounds can detect or image the accumulation of S100A9 in the body, aiding in the evaluation and monitoring of inflammatory diseases.

Career Highlights

Vogl has worked at the Westfaelische Wilhelms-Universitaet Muenster, where he has contributed to various research projects. His work has been instrumental in advancing the understanding of immunological methods and their applications in diagnostics.

Collaborations

Throughout his career, Vogl has collaborated with notable colleagues such as Johannes Roth and Andreas Faust. These collaborations have further enriched his research and innovations in the field.

Conclusion

Thomas Vogl's contributions to immunology through his patents demonstrate his commitment to advancing medical diagnostics. His innovative approaches to quantifying S100A12 and diagnosing inflammatory diseases highlight the importance of research in improving healthcare outcomes.